info@business-plan.co.za
Facebook
Business Plan Africa Investor-Ready Plans

LumaVida Women’s Health Institute Business Plan

Business Plan & Investor Prospectus

LumaVida Women’s Health Institute

A national network of premium women’s-health clinics

Integrated women’s-health network — obstetrics, gynaecology, fertility, longevity & oncology screening — flagship + nine provincial clinics · South Africa.

R25mSeed (Phase 1)
9Provincial clinics
>R180mYear-5 revenue
~225Jobs created

Start reading →

LumaVida Women’s Health Institute is raising a ZAR 25 million Phase-1 seed to roll out a capital-light national network of premium women’s-health clinics across South Africa — a flagship plus nine provincial clinics delivering obstetrics, gynaecology, fertility, longevity and oncology screening (with hospital partners for surgery), scaling toward more than ZAR 180 million of Year-5 revenue and around 225 jobs created, serving medical-aid members, private patients and corporate wellness. This plan sets out the clinical service model and clinic economics, market and competitive analysis, operations and clinical governance, patient-acquisition strategy, ESG and access, full financial projections, the investment case and an honest account of the key risks. Use the contents below to navigate the plan.

Financial snapshot

Two headline charts from the plan. Full projections and all visualisations are in Section 14: Financial Plan.

Figure 1. The specialist-supply constraint in women's health
Figure 2. The R25m seed is Phase 1 — not the full programme

Contents

Twenty sections. Each opens on its own page with previous / next navigation and a jump-to-section menu.

ⓘConfidentiality & important noticePlease read before reviewing the plan →

  1. 1Executive Summary
  2. 2Business Overview & Strategic Rationale
  3. 3The Clinical Service Model
  4. 4The Network & Clinic Economics
  5. 5Industry & Market Analysis
  6. 6Competitive Landscape & Positioning
  7. 7SWOT Analysis
  8. 8Marketing, Referral & Patient-Acquisition Strategy
  9. 9Operations, Clinical Governance & Technology
  10. 10Implementation Roadmap
  11. 11ESG, Access & Social Impact
  12. 12Management & Governance
  13. 13Risk Analysis & Mitigation
  14. 14Financial Plan
  15. 15Projected Profit & Loss
  16. 16Projected Balance Sheet
  17. 17Projected Cash Flow
  18. 18Debt Service, Cover Ratios & Returns
  19. 19Conclusion
  20. 20Appendices
Strictly private & confidential. This document is provided for information purposes only and does not constitute an offer to sell or a solicitation to buy securities. Financial projections are forward-looking, depend on assumptions that may not materialise, and are not guarantees of future performance. Figures in ZAR unless stated. External market data is indicative and should be independently verified. See the Confidentiality & Important Notice for the full basis of preparation.